Israel Englander Infinity Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.14 - $0.24 $16,937 - $29,035	-120,983 Reduced 32.56%	250,560 $52,000
Q1 2023 May 15, 2023	SELL	$0.16 - $0.74 $82,973 - $383,752	-518,585 Reduced 58.26%	371,543 $59,000
Q4 2022 Feb 14, 2023	BUY	$0.46 - $1.21 $22,445 - $59,041	48,795 Added 5.8%	890,128 $494,000
Q3 2022 Nov 14, 2022	SELL	$0.59 - $1.7 $608,343 - $1.75 Million	-1,031,090 Reduced 55.07%	841,333 $1 Million
Q2 2022 Aug 15, 2022	BUY	$0.49 - $1.2 $888,870 - $2.18 Million	1,814,022 Added 3106.15%	1,872,423 $1.18 Million
Q1 2022 May 16, 2022	SELL	$0.85 - $2.4 $582,139 - $1.64 Million	-684,870 Reduced 92.14%	58,401 $67,000
Q4 2021 Feb 14, 2022	SELL	$1.86 - $3.36 $4.11 Million - $7.42 Million	-2,208,665 Reduced 74.82%	743,271 $1.67 Million
Q3 2021 Nov 15, 2021	SELL	$1.52 - $3.82 $146,675 - $368,618	-96,497 Reduced 3.17%	2,951,936 $10.1 Million
Q2 2021 Aug 16, 2021	SELL	$2.66 - $3.47 $444,392 - $579,715	-167,065 Reduced 5.2%	3,048,433 $9.12 Million
Q1 2021 May 17, 2021	BUY	$1.98 - $5.36 $4.64 Million - $12.6 Million	2,341,544 Added 267.93%	3,215,498 $10.4 Million
Q4 2020 Feb 16, 2021	BUY	$1.05 - $2.77 $883,890 - $2.33 Million	841,800 Added 2618.03%	873,954 $1.85 Million
Q3 2020 Nov 16, 2020	BUY	$0.82 - $1.34 $5,332 - $8,714	6,503 Added 25.35%	32,154 $38,000
Q2 2020 Aug 14, 2020	BUY	$0.77 - $1.13 $19,751 - $28,985	25,651 New	25,651 $23,000
Q2 2019 Aug 14, 2019	SELL	$1.43 - $1.87 $161,958 - $211,792	-113,258 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$1.18 - $1.91 $51,321 - $83,071	43,493 Added 62.34%	113,258 $213,000
Q4 2018 Feb 14, 2019	SELL	$1.01 - $2.78 $24,790 - $68,235	-24,545 Reduced 26.03%	69,765 $82,000
Q3 2018 Nov 14, 2018	SELL	$1.72 - $2.71 $27,253 - $42,939	-15,845 Reduced 14.38%	94,310 $256,000
Q2 2018 Aug 14, 2018	SELL	$1.72 - $2.26 $373,592 - $490,883	-217,205 Reduced 66.35%	110,155 $210,000
Q1 2018 May 15, 2018	SELL	$1.8 - $2.74 $1.57 Million - $2.39 Million	-871,494 Reduced 72.69%	327,360 $687,000
Q4 2017 Feb 14, 2018	BUY	$1.22 - $3.73 $750,063 - $2.29 Million	614,806 Added 105.27%	1,198,854 $2.43 Million
Q3 2017 Nov 14, 2017	BUY	$0.94 - $1.35 $549,005 - $788,464	584,048	584,048 $777,000

Others Institutions Holding INFI

# of Institutions

Shares Held

1.26M

Call Options Held

Put Options Held

View Full List

About INFINITY PHARMACEUTICALS, INC.

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

More about INFI

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account